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Before embarking on any 
surgi cal enterprise with 
regard to the liver, it is 
essen tial to become familiar 
with the normal anatomy, 
function and regeneration/repair of the liver 
as well as the common variants in terms of 
blood supply (portal and systemic), venous 
drainage and the intra- and extrahepatic biliary 
anatomy (Fig. 1).[1] Paediatric liver tumours 
that may require liver transplantation are 
shown in Table 1.[2,3]
Disease assessment includes full imaging 
with ultrasound (US) and Doppler evaluation, 
computed tomography, magnetic resonance 
imaging with gadolinium, angiography and 
cholangiopancreatography. In children who 
may well receive preoperative chemotherapy, 
in most cases a diagnostic biopsy is preferred, 
usually a Trucut needle core, but laparoscopic 
or open wedge biopsies may be safer with 
regard to bleeding from the biopsy site. This 
would seem essential in infants <3 months and 
in children >3 years of age if there is a normal 
or near-normal serum α-fetoprotein level.[2,4,5]
There are a number of ways to assess and 
prognosticate the possible outcome of children 
with liver tumours and specifically with 
hepatoblastoma, the best known of these is the 
International Society of Pediatric Oncology 
(SIOP)’s pretreatment extent (PRETEXT) of 
disease system, which takes into account the 
extent of involvement of the four sectors of 
the liver and also notes extrahepatic growth 
using the letter V for hepatic vein, P for 
portal vein, M for metastases and E for 
extrahepatic lymph nodes.[4,5] This system has 
shown good reproducibility with a tendency 
to overstage, but it is an excellent predictor 
of survival. Additional information from a 
histopathological examination of the resected 
tumour, which would include the tumour’s 
multifocality, vascular invasion and cell 
type, increases the accuracy of prognosis.[6] 
Indicators of good prognosis are the presence 
of differentiating mesenchymal elements (i.e. 
fetal histology), therapy-related extent of 
necrosis of the resected tumour and quantity 
of viable mensenchyme (bone, muscle and 
cartilage).[6] An outline of management for 
hepatoblastoma and other malignant liver 
tumours is illustrated in Fig. 2. 
The principles of surgical management 
are to remove all of the tumour, and if this 
cannot be done even after chemotherapy, 
then transplantation should be considered.[3] 
In Internationale d’Oncologie Pediatrique 
– Epithelial Liver Study Group 2 (SIOPEL) 
the results of this conventional approach 
in standard-risk patients showed a 96% 
macroscopic resection rate and a 90% event-
free survival rate. In those high-risk cases 
with metastases, vascular invasion and 
extrahepatic resection, the resection rates 
were down to 66% and event-free survival 
was only 47%.[5,7] In our own series since 
1990 at Red Cross War Memorial Children’s 
Hospital, using the SIOPEL 3 protocol of 
chemotherapy, 44 of 49 patients underwent 
surgical resection with 41 survivors (83%). Of 
the 49, 1 was unresponsive to chemotherapy 
and 4 relapsed; 3 with lung metastases and 4 
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Fig. 1. Cholangiogram of a whole liver gra 
prior to being split into two functioning gra s for 
transplantation: segments 2,3 for a paediatric 
recipient and the right liver for an adult recipient. 
Note that the segment 2 duct joins the segment 7 duct 
before opening into the con uence of the right and 
le  hepatic ducts. A double anastomosis into a Roux-
en-Y hepaticojejunostomy of both the segments 2 and 
3 ducts would be required in this case.
Table 1. Paediatric liver tumours that may require liver transplantation
Malignant liver tumours Benign liver tumours Other liver tumours
Hepatoblastoma
Hepatocellular carcinoma (including 
fibrolamellar variant)
Transitional tumours
Epithelioid haemangioendothelioma
Undifferentiated embryonal sarcoma
Other sarcomas, e.g. angiosarcoma
Yolk sac tumour
Haemangioendothelioma
Mesenchymal hamartoma
Inflammatory 
pseudotumour or IMT
IMT = inflammatory myofibroblastic tumour.
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locally, of which 2 were lymph node-positive 
at surgery; none was transplanted. 
What then is the role of transplantation 
in our setting of a developing economy and 
uneven healthcare delivery? Accepted criteria 
for transplant should be an anatomically 
unresectable tumour, where complete removal 
can only be achieved by total hepatectomy (i.e. no 
extrahepatic residual intra-abdominal tumour).
[8] The tumour should be chemosensitive and 
all PRETEXT metastases should be cleared 
by chemotherapy. SIOP recommends early 
referral to a transplant surgeon in cases of: 
(i) multifocal or large solitary PRETEXT IV 
hepatoblastoma involving all four sectors of 
the liver; and (ii) unifocal, centrally located 
tumours involving main hilar structures or 
main hepatic veins. Because complete tumour 
resection is a prerequisite for cure, any strategy 
leading to an increased resection rate will 
result in an improved survival rate. SIOP 
advises the more frequent use of orthotopic 
liver transplant in those patients with tumour 
burden as described above, as well as the 
standardisation of techniques for partial liver 
resection.[9] Although SIOP’s guidelines 
should not be seen as final, but rather as a 
starting point for further discussion between 
the various national and international liver 
tumour study groups, it is indeed a moot point 
as to whether transplantation in our setting 
should be recommended so precipitously. 
The short-term results from transplantation 
are good, with >70% survival in most series 
(Table 2).[4,10] Clearly, transplantation should 
not be considered lightly, as it condemns a 
child to lifelong immunosuppressive therapy 
and the risk of graft dysfunction and 
rejection.[11] One should be reminded that the 
consequences of lifelong immunosuppressive 
therapy include impairment of renal function 
owing to a combination of chemotherapy 
and calcineurin inhibitor drug toxicity, 
dyslipidaemia, lymphoproliferative disease 
and other malignancies, e.g. Kaposi sarcoma, 
leiomyosarcoma, and skin, breast and 
gastrointestinal cancers.[12] It is therefore a 
reasonable discussion point as to how far one 
should go in order to avoid transplantation. 
There is of course the potential for rescue 
transplant after a failed resection with local 
recurrence, but the outcomes are less favourable 
than primary transplantation.[4,10] One can push 
the limits of surgery to the extreme in order 
to completely remove all tumours, even when 
in conventional terms the tumour may be 
considered unresectable. Examples include 
resecting a tumour with adjacent hepatic vein 
involvement and replacing the vein with a graft. 
On occasions where the main tumour involves 
most of the liver but segments 6 and 7 are 
clear, if there is a large accessory right hepatic 
vein as described by Baer et al., an extended 
left hepatectomy including segments 1 - 8 can 
be performed with preservation of adequate 
venous outflow via this vein (Fig. 3).[13-15]
Another extreme surgical concept 
is extending the hepatic resection with 
transplantation as an immediate back-up or 
saftey net should a complete resection, having 
been embarked on, turn out not to be possible. 
We did this in a 10-year-old boy with a large 
central fibrolamellar tumour, performing an 
extended left hepatectomy with Roux-en-Y 
drainage of an obstructed right segment 6,7 
bile duct with long-term success; the patient 
was healthy 17 years post resection.[16] 
In chemosensitive tumours, this strategy 
of resection can be extended to patients with 
multicentric tumours where satellite tumours 
in residual liver segments can be separately 
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Fig. 2. An outline of the overall algorithm of management options of hepatoblastoma in infants and 
children. Dierential diagnosis includes: FNH, HA, sarcoma is usually undierentiated embryonal 
sarcoma and HCC including the brolamellar variant (chemotherapeutically insensitive). Extreme 
surgery refers to extended hepatic resection and even bench surgery with autotransplantation. (FNH = 
focal nodular hyperplasia; HA = hepatic adenoma; HCC = hepatocellular carcinoma.)
Table 2. Results published of transplantation for malignant liver tumours in children – mainly hepatoblastoma
Authors Year Children, N Deceased donors, n Living donors, n Overall survival (%)
Al-Qabandi et al. 1999 8 8 0 62.5
Reyes et al. 2000 12 12 0 83.0
Molmenti et al. 2002 9 9 0 66.0
Pimpalwar et al. 2002 12 12 0 83.0
Chardot et al. 2002 4 0 4 75.0
Mejia et al. 2005 10 8 2 70.0
Kasahara et al. 2005 14 0 14 65.5
Otte et al. 2005 12 2 10 90.0
Avila et al. 2006 12 9 3 82.0
Chen et al. 2006 9 7 2 89.0
Beaunoyer et al. 2007 15 15 0 86.7
Faraj et al. 2007 25 18 7 77.6
Malek et al. 2010 54 - - 93.0
The studies in the table are cited in Otte et al.[4] and Malek et al.[10]
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excised in addition to the main tumour. Good 
preoperative imaging and intraoperative US 
is essential to identify all residual tumours. 
Likewise, when considering removal of a 
tumour, particularly a large tumour, one must 
think about the residual volume of liver that 
will remain and consider staged surgery with 
initial portal vein occlusion as a strategy to 
grow residual liver and avoid small-for-size 
syndrome.[17,18] Portal vein occlusion may be 
done as an open procedure, via a laparoscope or 
by using transhepatic interventional radiography 
and a variety of embolisation techniques and 
substances. The definitive surgical resection is 
carried out 2 - 4 weeks later, after ipsilateral 
atrophy and contralateral hyperplasia has 
occurred. The surgical options include resection 
of all hepatic tumours with an additional >1 cm 
margin around hepatocellular carcinomas; the 
other tumours, being chemotherapy sensitive, 
simply need free tumour margins as preference. 
The resections available are tumourectomy 
(non-anatomical), segmentectomy, (segments 
4a,b) central resection, hemihepatectomy (right 
or left liver, along Cantlie’s line), extended 
hepatectomy (right or left), staged resection 
after portal vein occlusion, ex vivo surgery 
with autotransplantation and transplantation, 
which may be primary or as rescue after local 
recurrence following a previous attempt at 
curative resection.[2,10,15]
Strategies for safe liver resection include 
protecting the liver during the resection with 
ischaemic preconditioning, avoiding any venous 
outflow obstruction from kinking or narrowing 
of the residual hepatic vein and reduction of 
postresection hyperperfusion, which may lead 
to congestion. This is done using a variety of 
techniques to reduce inflow of blood to the 
much smaller residual liver, which include 
splenic artery ligation, partial portosystemic 
shunting and the use of β-blockers such as 
propranolol. In the postoperative phase liver 
support in the intensive care unit is important. 
This may include the use of somatostatin, 
acetylcysteine, pentoxifylline and prostaglandin 
infusion, in addition to supplementing of 
clotting factors with fresh frozen plasma and 
vitamin K. Early commencement of enteral 
feeding is also trophic to the liver, but inevitably 
increases portal blood flow.[18] 
There are, of course, instances where tumour 
resection is not possible and transplantation 
is the only option. These would even 
include some benign tumours, such as a 
very extensive haemangioendothelioma not 
responding to treatment with β-blockers, 
chemotherapy or angioembolisation.[4] 
Causes of death in children transplanted 
for liver tumours are predominantly tumour 
recurrence (60% for hepatoblastoma and 
86% for hepatocellular carcinoma);  technical 
or immunosuppression/rejection-related 
complications are similar to those in children 
receiving liver transplants for other diseases.[12] 
Conclusion
The best results are achieved by a 
combination of elective resection in well-
selected cases, transplantation and rescue 
transplantation. Centres of hepatobiliary 
surgery should offer both extended hepatic 
resection and transplantation.[10] Extreme 
resections should be considered as an option, 
particularly where access to transplantation 
is suboptimal and where access to diligent 
long-term follow-up is challenging. If 
transplantation is the only option, then 
timing of the transplant is crucial. Ideally 
transplantation should be between courses 
of chemotherapy, with some post-transplant 
chemotherapy possible. Living donor 
transplant is preferred, because the timing 
of the transplant can be planned and the 
graft is usually of superior quality when 
compared with a deceased donor graft.
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Fig. 3. Residual liver a er a very extensive le  hepatectomy having hepatic venous return via a large 
preserved accessory right hepatic vein (2). All three main hepatic veins are ligated (1).  e right portal 
triad (3) is preserved.[13] (PV = portal vein.)
